0 Items
Toll Free (US) - +1-866-598-1553
sales@precisionbusinessinsights.com
Multiplex Assays Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017-2021 and Forecast 2022-2028

Multiplex Assays Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017-2021 and Forecast 2022-2028

$ PRICE - $ 3,000.00 – $ 8,900.00

Multiplex Assays Market By Product (Consumables, Instruments and Software Services), By Type (Protein & Nucleic Acid Assay), By Technology (Flow Cytometry, Fluorescence detection, Luminescence, Multiplex real-time PCR, Other technology), By Application (Research & development, Drug discovery & development, Biomarker discovery & validation, Clinical diagnostic), End User (Pharmaceutical and biotechnology companies, Hospitals, Research institutes, Clinical laboratories) and Geography

 

Request Sample Request Methodology
Request Sample Read More
$ PRICE - $ 3,000.00 – $ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00 – $ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Categories: ,
Report

Description

Multiplex Assays Market size was valued at USD 3.2 billion in 2021 and is expected to reach USD 5.4 billion by 2028, at a CAGR of 7.6% during the forecast period 2022 to 2028. Increase adoption of multiple assays compare to the traditional one because of the technology advancement like Nano technology which represents the ultra-miniaturization version of the conventional microarray is consider to be the key driver. More unit sample are required and high capital investment are anticipated to restrain which hung market growth during the forecast period of global multiplex assays market. Bio therapeutic R&D, cell gene therapy the global multiplex assay is the only approach hence opening up a intense of opportunity. The report studies global multiplex assays market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, global multiplex assays market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product Opportunities).

Multiplex Assays Market

MARKET SUMMARY
-
7.6%
  • Study Period– 2022 – 2028
  • Base Year– 2021
  • CAGR–7.6%
  • Largest Market– Asia Pacific
  • Fastest Growing Market–  North America

Multiplex Assays Market

  • The global multiplex assays market report gives comprehensive outlook on multiplex assays market across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa.
  • The report on global multiplex assays market gives historical, current, and future market sizes on the basis of product, type, application, technology, and region.
  • Key stakeholders of the global market report include suppliers, manufacturers, marketers, policy makers, and service providers engaged in global multiplex assays market
Key Players
  • Thermo Fisher Scientific Inc
  • Illumina Inc
  • Bio Rad Laboratories Inc
  • Qiagen, Abcam plc
  • BD
Multiplex Assays Market

DRIVERS AND RESTRAINTS

It is noticed that the global multiple assays market is influenced mainly by the number of R&D activities in forensic studies and mutation analysis which is the key factor causing the multiple assays market to grow. Accordingly, multi advantage properties include analyze multiple proteins simultaneously rather than having to run multiple assays to look for each protein separately. Running multiple assays means that there could be subtle variations in each run, which may impact the results hence boost up the global multiplex assay market. The ease with which STR profiles can be typed today has led to the development of large national databases containing STR profiles of millions of people suspected or convicted of crimes.

North-America Got Significant Share

Multiplex Assays Market

North America contributed major revenue followed by Europe and Asia Pacific. In 2019, North America region accounted huge growth rate and is anticipated to grow with a forecast year. However, it was an evident that the therapeutic market gaining interest in developing nations North America with a leading share of 44%. Development produced by well advanced healthcare and adopting new technology key factors that drive the growth of the market in this region and increase in patient population with Alzheimer disease. The European region is projected to observe a significant growth period due to increasing geriatric population included in system illness and chronic infection. Asia-Pacific is expected to register the highest CAGR during the forecast period contributing to the global multiple assay market.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East
Key

Features of the Report

  • Market players have witnessed the strategic collaboration and acquisition to expand product portfolio and strengthen their position in the market to enhance the revenue of the company.
  • In June 2018, QIAGEN (Germany) launched the QIAseq 16S/ITS Panels and UCP Multiplex PCR Kit. This kit was launched along with a new generation of reagents that allows the most accurate quantification and qualitative analysis from complex microbiome samples. This product provides a comprehensive and robust profiling of bacterial and fungal communities. With this launch, one more product got added to the company’s product portfolio.
  • In January 2016, Thermo Fisher Scientific acquired Affymetrix (U.S.). The acquisition of Affymetrix with Thermo Fisher Scientific helped Thermo Fisher Scientific Company in strengthening the biosciences field and creating new market opportunities for in genetic analysis
Multiplex Assays Market Segmentation

segmentation-block-image

product type

    • Consumable
    • Instrument
    • Software Services
segmentation-block-image

By Type

      • Protein Multiplex Assay
      1. Planer Protein Assay
      2. Bead-based Protein Assay
      • Nucleic Acid Multiplex Assay
      1. Planer Nucleic Acid Assay
      2. Bead-based Nucleic Acid Assay
      3. Other Nucleic Acid Assay
      • Cell-based Multiplex Assay
segmentation-block-image

By Technology

    • Flow Cytometry
    • Fluorescence Detection
    • Luminescence
    • Multiplex Real-time PCR
    • Other Technology
segmentation-block-image

By End User

    • Pharmaceutical and Biotechnology Companies
    • Hospitals
    • Research Institutes
    • Clinical laboratories
Location

GEOGRAPHY

Frequently Asked Questions

The Multiplex Assays Market is projected to expand at a CAGR of 7.6% during the forecast period.

  • Thermo Fisher Scientific Inc, Illumina Inc, Bio Rad Laboratories Inc, Qiagen, Abcam plc, BD

North America is is the fastest-growing region for Multiplex Assays Market

Report

Table Of Content

1. Executive Summary
2. Global Multiplex Assays Market Introduction
2.1. Global Multiplex Assays Market – Taxonomy
2.2. Global Multiplex Assays Market –Definitions
2.2.1. Product Type
2.2.2. Assay Type
2.2.3. Technology
2.2.4. Application
2.2.5. End User
3. Global Multiplex Assays Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Multiplex Assays Market Dynamic Factors – Impact Analysis
3.6. Global Multiplex Assays Market – Competition Landscape
4. Global Multiplex Assays Market Analysis,2017 – 2021 and Forecast, 2022 – 2028
4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Multiplex Assays Market, By Product Type, 2017–2021and Forecast, 2022–2028 (Revenue, USD Mn)
5.1. Reagents & Consumables
5.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Instruments & Accessories
5.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Software & Services
5.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
6. Global Multiplex Assays Market, By Assay Type, 2017 – 2021 and Forecast, 2021 – 2027 (Revenue, USD Mn)
6.1. Protein Based Multiplex Assays
6.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Nucleic Acid-Based Multiplex Assay
6.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Other Multiplex Assays
6.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
7. Global Multiplex Assays Market Forecast, By Technology,2017–2021and Forecast, 2022–2028 (Revenue, USD Mn)
7.1. Flow Cytometry
7.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Fluorescence Detection
7.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Luminescence
7.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Multiplex Real-Time PCR
7.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
7.5. Others
7.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.5.3. Market Opportunity Analysis
8. Global Multiplex Assays Market Forecast, By Application, 2017 – 2021 and Forecast, 2021 – 2027 (Revenue, USD Mn)
8.1. Research & Development
8.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Clinical Diagnostics
8.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
9. Global Multiplex Assays Market, By End User, 2017 – 2021 and Forecast, 2021 – 2027 (Revenue, USD Mn)
9.1. Pharmaceutical & Biotechnology Companies
9.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.1.3. Market Opportunity Analysis
9.2. Hospitals & Clinics
9.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.2.3. Market Opportunity Analysis
9.3. Diagnostic and Reference Laboratories
9.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.3.3. Market Opportunity Analysis
9.4. Academic and Research Institutes
9.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.4.3. Market Opportunity Analysis
9.5. Others
9.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.5.3. Market Opportunity Analysis
10. Global Multiplex Assays Market Forecast, By Region, 2017–2021and Forecast, 2022–2028(Revenue, USD Mn)
10.1. North America
10.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
10.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
10.1.3. Market Opportunity Analysis
10.2. Europe
10.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
10.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
10.2.3. Market Opportunity Analysis
10.3. Asia-Pacific
10.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
10.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
10.3.3. Market Opportunity Analysis
10.4. Latin America
10.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
10.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
10.4.3. Market Opportunity Analysis
10.5. Middle East and Africa
10.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
10.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
10.5.3. Market Opportunity Analysis
10.6. Global Multiplex Assays Market – Opportunity Analysis Index, By Product Type, Assay Type, Technology, Application, End User, and Region, 2022 – 2028
11. North America Multiplex Assays MarketAnalysis,2017–2021and Forecast, 2022–2028(Revenue, USD Mn)
11.1. Product Type Analysis 2017–2021and Forecast 2022 – 2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
11.1.1. Reagents & Consumables
11.1.2. Instruments & Accessories
11.1.3. Software & Services
11.2. Assay Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.2.1. Protein Based Multiplex Assays
11.2.2. Nucleic Acid-Based Multiplex Assay
11.2.3. Other Multiplex Assays
11.3. Technology Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. Flow Cytometry
11.3.2. Fluorescence Detection
11.3.3. Luminescence
11.3.4. Multiplex Real-Time PCR
11.3.5. Others
11.4. Application Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.4.1. Research & Development
11.4.2. Clinical Diagnostics
11.5. End User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.5.1. Pharmaceutical & Biotechnology Companies
11.5.2. Hospitals and Clinics
11.5.3. Diagnostic and Reference Laboratories
11.5.4. Academic and Research Institutes
11.5.5. Others
11.6. Country Analysis 2017 – 2021 and Forecast 2022 – 2028by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.6.1. USA
11.6.2. Canada
11.7. North America Multiplex Assays Market – Opportunity Analysis Index, By Product Type, Assay Type, Technology, Application, End User and Country, 2022 – 2028
11.8. North America Multiplex Assays Market Dynamics – Trends
12. Europe Multiplex Assays Market Analysis, 2017–2021and Forecast, 2022–2028(Revenue, USD Mn)
12.1. Product Type Analysis 2017–2021and Forecast 2022 – 2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
12.1.1. Reagents & Consumables
12.1.2. Instruments & Accessories
12.1.3. Software & Services
12.2. Assay Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.2.1. Protein Based Multiplex Assays
12.2.2. Nucleic Acid-Based Multiplex Assay
12.2.3. Other Multiplex Assays
12.3. Technology Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.3.1. Flow Cytometry
12.3.2. Fluorescence Detection
12.3.3. Luminescence
12.3.4. Multiplex Real-Time PCR
12.3.5. Others
12.4. Application Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.4.1. Research & Development
12.4.2. Clinical Diagnostics
12.5. End User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.5.1. Pharmaceutical & Biotechnology Companies
12.5.2. Hospitals and Clinics
12.5.3. Diagnostic and Reference Laboratories
12.5.4. Academic and Research Institutes
12.5.5. Others
12.6. Country Analysis 2017–2021and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.6.1. Germany
12.6.2. UK
12.6.3. France
12.6.4. Spain
12.6.5. Italy
12.6.6. Rest of Europe
12.7. Europe Multiplex Assays Market – Opportunity Analysis Index, By Product Type, Assay Type, Technology, Application, End User, and Country, 2022 – 2028
12.8. Europe Multiplex Assays Market Dynamics – Trends
13. Asia-Pacific Multiplex Assays Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
13.1. Product Type Analysis 2017–2021and Forecast 2022 – 2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
13.1.1. Reagents & Consumables
13.1.2. Instruments & Accessories
13.1.3. Software & Services
13.2. Assay Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.2.1. Protein Based Multiplex Assays
13.2.2. Nucleic Acid-Based Multiplex Assay
13.2.3. Other Multiplex Assays
13.3. Technology Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.3.1. Flow Cytometry
13.3.2. Fluorescence Detection
13.3.3. Luminescence
13.3.4. Multiplex Real-Time PCR
13.3.5. Others
13.4. Application Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.4.1. Research & Development
13.4.2. Clinical Diagnostics
13.5. End User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.5.1. Pharmaceutical & Biotechnology Companies
13.5.2. Hospitals and Clinics
13.5.3. Diagnostic and Reference Laboratories
13.5.4. Academic and Research Institutes
13.5.5. Others
13.6. Country Analysis2017–2021and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.6.1. Japan
13.6.2. China
13.6.3. India
13.6.4. ASEAN
13.6.5. Australia & New Zealand
13.6.6. Rest of Asia-Pacific
13.7. Asia-Pacific Multiplex Assays Market – Opportunity Analysis Index, By Product Type, Assay Type, Technology, Application, End User, and Country,2022 – 2028
13.8. Asia-Pacific Multiplex Assays Market Dynamics – Trends
14. Latin America Multiplex Assays Market Analysis,2017 – 2021 and Forecast, 2022–2028(Revenue, USD Mn)
14.1. Product Type Analysis 2017–2021and Forecast 2022 – 2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
14.1.1. Reagents & Consumables
14.1.2. Instruments & Accessories
14.1.3. Software & Services
14.2. Assay Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.2.1. Protein Based Multiplex Assays
14.2.2. Nucleic Acid-Based Multiplex Assay
14.2.3. Other Multiplex Assays
14.3. Technology Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.3.1. Flow Cytometry
14.3.2. Fluorescence Detection
14.3.3. Luminescence
14.3.4. Multiplex Real-Time PCR
14.3.5. Others
14.4. Application Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.4.1. Research & Development
14.4.2. Clinical Diagnostics
14.5. End User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.5.1. Pharmaceutical & Biotechnology Companies
14.5.2. Hospitals and Clinics
14.5.3. Diagnostic and Reference Laboratories
14.5.4. Academic and Research Institutes
14.5.5. Others
14.6. Country Analysis 2017–2021and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Argentina
14.6.4. Rest of Latin America
14.7. Latin America Multiplex Assays Market – Opportunity Analysis Index, By Product Type, Assay Type, Technology, Application, End User, and Country, 2022 – 2028
14.8. Latin America Multiplex Assays Market Dynamics – Trends
15. Middle East and Africa Multiplex Assays Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
15.1. Product Type Analysis 2017–2021and Forecast 2022 – 2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
15.1.1. Reagents & Consumables
15.1.2. Instruments & Accessories
15.1.3. Software & Services
15.2. Assay Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
15.2.1. Protein Based Multiplex Assays
15.2.2. Nucleic Acid-Based Multiplex Assay
15.2.3. Other Multiplex Assays
15.3. Technology Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
15.3.1. Flow Cytometry
15.3.2. Fluorescence Detection
15.3.3. Luminescence
15.3.4. Multiplex Real-Time PCR
15.3.5. Others
15.4. Application Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
15.4.1. Research & Development
15.4.2. Clinical Diagnostics
15.5. End User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
15.5.1. Pharmaceutical & Biotechnology Companies
15.5.2. Hospitals and Clinics
15.5.3. Diagnostic and Reference Laboratories
15.5.4. Academic and Research Institutes
15.5.5. Others
15.6. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
15.6.1. Gulf Cooperation Council (GCC) Countries
15.6.2. Israel
15.6.3. South Africa
15.6.4. Rest of MEA
15.7. MEA Multiplex Assays Market – Opportunity Analysis Index, By Product Type, Assay Type, Technology, Application, End User, and Country, 2022 – 2028
15.8. MEA Multiplex Assays Market Dynamics – Trends
16. Competition Landscape 
16.1. Strategic Dashboard of Top Market Players
16.2. Company Profiles (Introduction, Financial Analysis, Product Type& Service Assay Types, Key Developments, Strategies, and SWOT Analysis)
16.2.1. Thermo Fisher Scientific Inc.
16.2.2. Illumina Inc.
16.2.3. Bio-Rad Laboratories Inc.
16.2.4. QIAGEN N.V.
16.2.5. Becton, Dickinson and Company
16.2.6. Abcam PLC
16.2.7. Seegene Inc.
16.2.8. Randox Laboratories Ltd.
16.2.9. Merck KGaA
16.2.10. Promega Corporation
17. Research Methodology
18. Key Assumptions and Acronyms
Report

Company Profile

  • Thermo Fisher Scientific Inc
  • Illumina Inc
  • Bio Rad Laboratories Inc
  • Becton, Dickinson and Company
  • Abcam PLC
  • Seegene Inc.
  • Randox Laboratories Ltd.
  •  Merck KGaA
  • Promega Corporation

Description

Multiplex Assays Market size was valued at USD 3.2 billion in 2021 and is expected to reach USD 5.4 billion by 2028, at a CAGR of 7.6% during the forecast period 2022 to 2028. Increase adoption of multiple assays compare to the traditional one because of the technology advancement like Nano technology which represents the ultra-miniaturization version of the conventional microarray is consider to be the key driver. More unit sample are required and high capital investment are anticipated to restrain which hung market growth during the forecast period of global multiplex assays market. Bio therapeutic R&D, cell gene therapy the global multiplex assay is the only approach hence opening up a intense of opportunity. The report studies global multiplex assays market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, global multiplex assays market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product Opportunities).

ASIA PACIFIC OFFICE

Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad - 500072

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX

QUICKLINKS
RESEARCH AREAS
PRESS RELEASE
CONTACT US
+1-866-598-1553
EMAIL
sales@precisionbusinessinsights.com
FOLLOW US
QUICK LINKS+
RESEARCH AREAS+
PRESS RELEASE+
CONTACT US+
+1-866-598-1553
sales@precisionbusinessinsights.com
FOLLOW US AT+